If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
The Journal of Substance Use and Addiction Treatment (JSAT) features original research; systematic reviews and meta-analyses; and commentaries and symposia/conference proceedings that advance the care of substance use disorders (including alcohol, illicit and prescription drugs, cannabis and nicotine) and their consequences.
JSAT values high-quality empirical research relevant to the care of persons with substance use problems by scholars, clinicians, and scientists in all disciplines, in any setting. In general, JSAT articles should address policies, systems of care, assessment techniques, and intervention approaches that have clear relevance for addiction treatment, harm reduction, and recovery support. JSAT is particularly interested in addiction health services research, including the design, organization, delivery, implementation, accessibility, quality, cost, effectiveness, equity, patient experience, and workforce characteristics of interventions for persons with substance use problems in all service settings.
The Editors of JSAT seek to amplify the voices of persons, families, researchers, and clinicians affected by substance use disorder (SUD) and its treatment. A monthly recurring section called “Lived Experience” seeks short, narrative, non-fiction that has implications for the care of persons with SUD. Of particular interest are pieces that honor stories of addiction and recovery, mitigate stigma through a humanized portrayal of persons, families and caregivers affected by SUD, raise issues of social justice and inequity, explore the dynamics of patient-clinician relationships, and foster compassionate engagement with people with SUD. Review criteria will give preference to brief memoirs, true stories, and personal essays that are compelling, well-crafted, and authentic. Work that focuses on specific episodes with universal implications will do better in review than diffuse tales of recovery. Although anonymity or use of a pseudonym is permitted, preference will be given to personal stories or autobiographical work from an identifiable author to normalize discussion of SUD and reduce its associated stigma.
If an individual described in these manuscripts is identifiable, a Permission Form, which provides consent for publication, must be completed and signed by the individual or family member(s) and submitted with the manuscript. Manuscripts that describe identifiable individuals that do not have a signed form will not be reviewed. Omitting information or making such information less specific to deidentify individuals is acceptable, but fictional or composite accounts are not permitted.
Manuscripts are limited to 1600 words and must have no more than three authors. All manuscripts must be submitted formally via the journal's manuscript submission system. We will not review drafts or unfinished manuscripts prior to submission.
JSAT Call for Papers for Special Issue: Stimulant Use Disorder
The Journal of Substance Abuse Treatment seeks articles on the changing epidemiology and treatment of stimulant use disorder for a planned Special Issue. JSAT prefers empirical research, however, we will also consider systematic reviews and meta analyses.
Recent reports from CDC and other sources has documented that cocaine and methamphetamine play an increasing role in the overdose death crisis in the US. We think a special issue presenting new information on a variety of stimulant-related research topics is merited.
We invite high quality research manuscripts on topics related to stimulant use disorder, such as:
Behavioral and pharmacotherapy innovations
Implementation and dissemination science
Treatment in medical and specialty care settings
Assessment and treatment of co-occurring psychiatric symptoms (psychosis, depression)
Overdose prevention and overdose treatment
Epidemiological and treatment studies addressing racial, ethnic, sexual, and/or gender minority populations, as well as rural communities
The due date for abstracts is March 1, 2022. Abstracts will be peer-reviewed and decisions will be announced no later than April 1, 2022. Papers invited for submission will be due on September 1, 2022. All submitted manuscripts will go through a rigorous peer-reviewed process, thus acceptance of your abstract does not guarantee publication. Accepted manuscripts will be published online on a rolling basis (prior to the full special issue being published in late 2022).
Please email any questions to the guest editors below.